We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$269K
Cap. Flow
+$263K
Cap. Flow %
0.23%
Top 10 Hldgs %
19.61%
Holding
199
New
30
Increased
53
Reduced
57
Closed
37

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$1.14M
2
SYY icon
Sysco
SYY
+$1.14M
3
BNY
Bank of New York Mellon
BNY
+$1.11M
4
KMB icon
Kimberly-Clark
KMB
+$1.08M
5
AMGN icon
Amgen
AMGN
+$1.01M

Sector Composition

Rank Sector Weight
1 Industrials 18.96%
2 Healthcare 18.74%
3 Technology 14.93%
4 Consumer Staples 12.75%
5 Financials 12.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$618B
$3.04M 2.61%
30,208
+1,704
+6% +$173K
CHD icon
2
Church & Dwight Co
CHD
$23.4B
$3.02M 2.6%
70,700
QCOM icon
3
Qualcomm
QCOM
$155B
$2.35M 2.02%
33,890
+500
+1% +$35.2K
XOM icon
4
ExxonMobil
XOM
$644B
$2.3M 1.98%
27,039
-764
-3% -$67.7K
AMGN icon
5
Amgen
AMGN
$208B
$2.22M 1.91%
13,875
+6,400
+86% +$1.01M
KMB icon
6
Kimberly-Clark
KMB
$36.3B
$2.14M 1.84%
20,003
+9,750
+95% +$1.08M
GE icon
7
GE Aerospace
GE
$374B
$2.06M 1.77%
17,299
-261
-1% -$31.1K
AB icon
8
AllianceBernstein
AB
$3.43B
$2.04M 1.76%
66,161
-2,050
-3% -$55.7K
KLAC icon
9
KLA
KLAC
$239B
$1.85M 1.59%
317,050
+178,000
+128% +$1.14M
IHG icon
10
InterContinental Hotels
IHG
$23.9B
$1.8M 1.54%
34,760
-1,973
-5% -$104K
TFC icon
11
Truist Financial
TFC
$63.3B
$1.68M 1.44%
43,040
+10,525
+32% +$397K
UPS icon
12
United Parcel Service
UPS
$88.6B
$1.57M 1.35%
16,150
+4,855
+43% +$498K
SYY icon
13
Sysco
SYY
$40.8B
$1.56M 1.34%
41,270
+28,820
+231% +$1.14M
CELG
14
DELISTED
Celgene Corp
CELG
$1.44M 1.23%
12,450
+1,325
+12% +$158K
MRK icon
15
Merck
MRK
$322B
$1.35M 1.16%
24,567
+2,907
+13% +$165K
AVT icon
16
Avnet
AVT
$7.29B
$1.34M 1.16%
30,225
-300
-1% -$13.2K
URI icon
17
United Rentals
URI
$67.2B
$1.29M 1.11%
14,125
+5,725
+68% +$515K
DD icon
18
DuPont de Nemours
DD
$18.5B
$1.29M 1.11%
10,583
EMR icon
19
Emerson Electric
EMR
$83.9B
$1.27M 1.09%
22,370
-501
-2% -$29.1K
PFE icon
20
Pfizer
PFE
$143B
$1.2M 1.03%
36,374
-1,660
-4% -$52.8K
CSX icon
21
CSX Corp
CSX
$93.4B
$1.17M 1%
105,735
+38,775
+58% +$446K
CNW
22
DELISTED
CON-WAY INC.
CNW
$1.16M 0.99%
26,175
+9,325
+55% +$411K
BNY
23
Bank of New York Mellon
BNY
$106B
$1.14M 0.98%
+28,400
New +$1.11M
TSN icon
24
Tyson Foods
TSN
$20.4B
$1.09M 0.94%
28,600
+6,000
+27% +$240K
PG icon
25
Procter & Gamble
PG
$336B
$1.09M 0.94%
13,294
+1,264
+11% +$109K

Similar funds

New England Research & Management's Q1 2015 Portfolio in Review

As of Q1 2015, New England Research & Management held 199 positions worth $116M, down 0.23% from $117M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

New England Research & Management's Q1 2015 filing shows 30 new, 53 increased, 57 reduced and 37 closed positions. Its largest new stake was Bank of New York Mellon: 28,400 shares worth $1.14M. The largest sale was Canadian National Railway, an estimated $1.4M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q1 2015 buy was Bank of New York Mellon: 28,400 shares worth $1.14M.
  • New England Research & Management added most to KLA in Q1 2015, an estimated $1.14M increase.
  • New England Research & Management's biggest Q1 2015 reduction was Parexel International Corp, cutting an estimated $1.1M.
  • New England Research & Management fully exited Canadian National Railway in Q1 2015, selling an estimated $1.4M.
  • New England Research & Management's ten largest holdings make up 20% of its $116M portfolio in Q1 2015.
  • New England Research & Management opened 30 new positions and closed 37 in Q1 2015.
  • New England Research & Management's portfolio value fell 0.23% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q1 2015, filed 6 Apr 2015.